Using Non-Invasive Respiratory Monitoring for COVID-19 Pulmonary Embolism Diagnosis

The Permanente Journal

article

Jeffery M Cohen¹  Shawn R Winnick²  Anna Finkelstein¹  Gonzalo Custodio¹  Irene H Jo¹  Jennifer Naughton¹  Sangita Nicholas¹  John Lee¹  Vimal Desai¹  Matthew Alonzo¹  Dicky H Shah¹  Chunyuan Qiu¹ 

[1] Kaiser Permanente Baldwin Park Medical Center;Kaiser Permanente Fontana Medical Center

关键词: Pulmonary Embolism;    Pneumonia;    COVID-19;    Case Report;   

DOI  :  10.7812/TPP/22.059

学科分类：医学（综合）

来源: Permanente Medical Group

【 摘 要 】

With the high incidence rate of pulmonary embolism (PE) and pneumonia reported in hospitalized patients with COVID-19, the ability to determine the dominant etiology for severe respiratory distress quickly and accurately is crucial to a patient’s well-being. Traditionally, D-dimer blood tests and diagnostic imaging studies would be utilized to determine the presence of a PE or a venous thromboembolism. However, COVID-19 places patients in a prothrombotic state and performing diagnostic imaging studies on all patients with COVID-19 would be impractical, making the need for a simple and reliable method to determine the likelihood of PE or venous thromboembolism a priority for emergency departments. The authors believe the use of non-invasive respiratory monitoring technology to assess lung function in hospitalized patients with COVID-19 can aid in discerning the dominant hypoxia etiology and tailoring of their treatment. Here, the authors outline a case and method of using non-invasive respiratory monitoring of lung function in the successful diagnosis of a PE in a 62-year-old patient with COVID-19.

【 授权许可】

Unknown